Neurocrine Biosciences shares owned by Verition Fund Management
Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Verition Fund Management
from 13F filings
Historical chart of Verition Fund Management investment in Neurocrine Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Neurocrine Biosciences held by Verition Fund Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neurocrine Biosciences by Verition Fund Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $5.4M | 39k | 140.38 |
| 2025-06-30 | $6.0M | 48k | 125.69 |
| 2025-03-31 | $2.0M | 18k | 110.60 |
| 2024-12-31 | $1.5M | 11k | 136.50 |
| 2024-09-30 | $959k | 8.3k | 115.22 |
| 2024-03-31 | $580k | 4.2k | 137.92 |
| 2023-09-30 | $4.6M | 41k | 112.50 |
| 2023-06-30 | $4.2M | 45k | 94.30 |
| 2023-03-31 | $7.0M | 70k | 101.22 |
| 2022-12-31 | $569k | 4.8k | 119.44 |
| 2022-09-30 | $302k | 2.8k | 106.19 |
| 2022-06-30 | $369k | 3.8k | 97.36 |
| 2022-03-31 | $9.7M | 104k | 93.75 |
| 2021-06-30 | $4.2M | 43k | 97.31 |
| 2021-03-31 | $624k | 6.4k | 97.27 |
| 2020-12-31 | $10M | 104k | 95.85 |
| 2020-09-30 | $495k | 5.1k | 96.21 |
| 2020-06-30 | $317k | 2.6k | 121.83 |
| 2019-12-31 | $1.6M | 15k | 107.52 |
| 2019-09-30 | $272k | 3.0k | 90.25 |
| 2019-03-31 | $339k | 3.8k | 88.19 |
| 2018-09-30 | $3.5M | 29k | 122.95 |
| 2018-03-31 | $360k | 4.3k | 83.01 |
| 2017-12-31 | $649k | 8.4k | 77.62 |